iCover作为桥接支架在开窗式主动脉腔内修复术中的应用
该回顾性单中心研究评估了iCover支架作为桥接支架在开窗式腔内主动脉瘤修复术中的初步结局和耐久性,共纳入28例患者使用94枚iCover支架供应87根目标血管,iCover相关目标血管不稳定豁免率达94%,技术成功率高,但随访期间需再干预,住院死亡率为7%。
要点
- iCover支架相关目标血管不稳定豁免率为94%(82/87)。
- 技术成功率:初期成功94%,二次成功99%。
- 住院死亡率为7%(n=4),无死亡直接归因于iCover支架相关问题。
核心结论
- iCover支架作为开窗式腔内主动脉瘤修复术中的桥接支架显示出有希望的初步结局,技术成功率高,目标血管不稳定率令人满意,需要持续监测和进一步研究以评估长期耐久性和结局。
研究设计与样本
- 回顾性单中心研究,筛选2021年8月至2024年1月期间复杂主动脉瘤手术,纳入使用iCover支架作为桥接支架行开窗式腔内主动脉瘤修复术的患者,共28例患者,使用94枚iCover支架供应87根目标血管。
主要发现
- 整个研究期间iCover支架相关目标血管不稳定豁免率达94%(82/87)。
- 初期技术成功率为94%,二次技术成功率为99%。
- 随访期间因iCover支架相关原因需再干预,包括4例内漏、2例T1cEL和2例T3cEL。
- 住院死亡率为7%(n=4),其中2例归因于术中并发症,无死亡直接归因于iCover支架相关问题。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Complex endovascular repair with fenestrated or branched stent grafts is a common approach for treating various types of aortic aneurysms. Bridging stent grafts (BSs) are crucial in connecting aortic endoprosthesis to target vessels, yet current options have demonstrated significant complications. OBJECTIVE: This retrospective single-center study evaluates the initial outcomes and durability of the iCover stent graft (iCover-SG) when used as a BS in fenestrated endovascular aneurysm repair (FEVAR). METHODS: Retrospective analysis screened procedures for complex aortic aneurysms between August 2021 and January 2024. Patients who underwent FEVAR with iCover-SG as BS were included. Primary and secondary endpoints focused on freedom from iCover-SG-related target vessel instability, technical success, and postoperative outcomes. RESULTS: Within the cohort of 28 patients, 94 iCover-SGs were used as BS, supplying 87 target vessels. The freedom from iCover-SG-related target vessel instability throughout the study reached 94% (82/87). Technical success rates were notably high, with primary success achieved in 94% of cases and secondary success in 99%. Over the follow-up duration, there were instances necessitating reintervention related to iCover-SG, including 4 cases of endoleak, 2 cases of T1cEL, and 2 cases of T3cEL. In-hospital mortality was 7% (n=4), with 2 cases attributed to intraoperative complications. Importantly, no deaths were directly attributed to iCover-SG-related issues. CONCLUSION: The iCover-SG demonstrates promising initial outcomes as a BS in FEVAR, with high technical success rates and satisfactory rates of target vessel instability. Continued monitoring and further studies are warranted to assess long-term durability and outcomes.Clinical ImpactThis study shows that the iCover stent graft achieves satisfactory technical success and target vessel stability in the short- and mid-term when used as a bridging stent graft in FEVAR procedures. Its successful integration into clinical practice broadens the range of available options, providing clinicians with more versatile tools for managing complex endovascular aortic aneurysms. This expanded selection of bridging stent grafts allows for more personalised treatment strategies, improving procedural precision and patient outcomes. The iCover stent graft's reliable performance highlights its potential as a valuable addition to current endovascular techniques, ultimately enhancing patient care in challenging cases.
引用
- Menges AL, Landré V, Meuli L, et al. iCover as Bridging Stent Graft in Fenestrated Endovascular Aortic Aneurysm Repair. J Endovasc Ther. 2024. PMID: 39239963. doi:10.1177/15266028241270862
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。